Cell MedX CorpOTC Pink - Current Information:CMXC
- LAST PRICE0.0480
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0480
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CMXC |
|---|---|---|
| 09:57 ET | 5000 | 0.048 |
| 12:48 ET | 10510 | 0.048 |
| 02:54 ET | 10000 | 0.048 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cell MedX Corp | 14.3M | -16.6x | --- |
Enzolytics Inc | 14.4M | 0.0x | --- |
Edesa Biotech Inc | 14.0M | -1.7x | --- |
NanoViricides Inc | 13.8M | -1.5x | --- |
Kiora Pharmaceuticals Inc | 13.4M | -0.2x | --- |
Curative Biotechnology Inc | 15.2M | -2.3x | --- |
Company Information
Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.
Contact Information
- Headquarters
- 123 W. Nye Ln, Suite 446CARSON CITY, NV, United States 89706
- Phone
- 310-508-9398
- Fax
- 775-884-9383
Executives
- Chief Executive Officer, Director
- David Jeffs
- Chief Financial Officer, Treasurer, Corporate Secretary, Director
- Yanika Silina
- Director
- Amir Vahabzadeh
- Director
- Dwayne Yaretz
- Independent Director
- George Adams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.3M |
|---|---|
Revenue (TTM) | $70.00 |
Shares Outstanding | 297.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.04 |
P/E Ratio | -16.6x |
Price/Sales (TTM) | 203,819.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,928.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
